Calvert Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-101,488
Closed -$9.33M 171
2016
Q4
$9.33M Sell
101,488
-12,046
-11% -$1.04M 0.35% 80
2016
Q3
$9.61M Sell
113,534
-6,312
-5% -$530K 0.35% 82
2016
Q2
$9.76M Buy
119,846
+77,465
+183% +$5.9M 0.39% 76
2016
Q1
$3.03M Buy
42,381
+678
+2% +$45.5K 0.13% 156
2015
Q4
$2.97M Sell
41,703
-5,226
-11% -$351K 0.14% 150
2015
Q3
$2.88M Sell
46,929
-52,713
-53% -$3.68M 0.14% 134
2015
Q2
$7.23M Sell
99,642
-31,518
-24% -$2.33M 0.32% 80
2015
Q1
$10.1M Sell
131,160
-12,359
-9% -$885K 0.65% 42
2014
Q4
$9.62M Buy
143,519
+21,218
+17% +$1.34M 0.66% 40
2014
Q3
$7.42M Buy
122,301
+7,310
+6% +$450K 0.55% 56
2014
Q2
$6.75M Buy
114,991
+78,400
+214% +$4.59M 0.45% 70
2014
Q1
$2.12M Buy
+36,591
New +$1.96M 0.15% 126

Other funds holding DGX

Calvert Investment Management's DGX Position: Q1 2017 in Review

Calvert Investment Management sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 101,488 shares — an estimated $9.33M sold.

Calvert Investment Management first reported a position in DGX in Q1 2014 and held it in 12 quarters. The position peaked at $10.1M in Q1 2015. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Calvert Investment Management reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 101,488 Quest Diagnostics shares in Q1 2017, an estimated $9.33M.
  • Calvert Investment Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 12 quarters.
  • Calvert Investment Management's Quest Diagnostics position peaked at $10.1M in Q1 2015.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.